Overview

Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving motexafin gadolinium together with radiation therapy works in treating young patients with pontine glioma. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs, such as motexafin gadolinium, may make tumor cells more sensitive to radiation therapy. Giving motexafin gadolinium together with radiation therapy may kill more tumor cells.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Motexafin gadolinium